Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 7

Results: 31

The role of microRNA in human leukemia: a review.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1257, doi. 10.1038/leu.2008.382

By:

Yendamuri, S.;
Calin, G. A.

Publication type:

Article

Genomic tools for dissecting oncogenic transcriptional networks in human leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1236, doi. 10.1038/leu.2008.394

By:

Palomero, T.;
Ferrando, A. A.

Publication type:

Article

Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1311, doi. 10.1038/leu.2009.20

By:

Cui, J.-W.;
Vecchiarelli-Federico, L. M.;
Li, Y.-J.;
Wang, G.-J.;
Ben-David, Y.

Publication type:

Article

CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.

Published in:

2009

By:

Takeshita, A.;
Yamakage, N.;
Shinjo, K.;
Ono, T.;
Hirano, I.;
Nakamura, S.;
Shigeno, K.;
Tobita, T.;
Maekawa, M.;
Kiyoi, H.;
Naoe, T.;
Ohnishi, K.;
Sugimoto, Y.;
Ohno, R.

Publication type:

Correction Notice

GATA-1 and GATA-2 binding to 3′ enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1270, doi. 10.1038/leu.2009.13

By:

Furuhata, A.;
Murakami, M.;
Ito, H.;
Gao, S.;
Yoshida, K.;
Sobue, S.;
Kikuchi, R.;
Iwasaki, T.;
Takagi, A.;
Kojima, T.;
Suzuki, M.;
Abe, A.;
Naoe, T.;
Murate, T.

Publication type:

Article

Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome.

Published in:

2009

By:

Zou, J. X.;
Rollison, D. E.;
Boulware, D.;
Chen, D.-T.;
Sloand, E. M.;
Pfannes, L. V.;
Goronzy, J. J.;
Bai, F.;
Painter, J. S.;
Wei, S.;
Cosgrove, D.;
List, A. F.;
Epling-Burnette, P. K.

Publication type:

journal article

Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1209, doi. 10.1038/leu.2009.18

By:

Mullighan, C. G.;
Downing, J. R.

Publication type:

Article

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.

Published in:

2009

By:

Wang, M.;
Sun, L.;
Qian, J.;
Han, X.;
Zhang, L.;
Lin, P.;
Cai, Z.;
Yi, Q.

Publication type:

journal article

Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1264, doi. 10.1038/leu.2009.12

By:

Prucker, C.;
Attarbaschi, A.;
Peters, C.;
Dworzak, M. N.;
Pötschger, U.;
Urban, C.;
Fink, F.-M.;
Meister, B.;
Schmitt, K.;
Haas, O. A.;
Gadner, H.;
Mann, G.

Publication type:

Article

Toward a systems biology approach to investigate cellular networks in normal and malignant B cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1219, doi. 10.1038/leu.2009.4

By:

Basso, K.

Publication type:

Article

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer.

Published in:

2009

By:

Ebert, B. L.

Publication type:

journal article

Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies.

Published in:

2009

By:

Triplett, B. M.;
Horwitz, E. M.;
Iyengar, R.;
Turner, V.;
Holladay, M. S.;
Gan, K.;
Behm, F. G.;
Leung, W.

Publication type:

journal article

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome.

Published in:

2009

By:

Garg, R.;
Faderl, S.;
Garcia-Manero, G.;
Cortes, J.;
Koller, C.;
Huang, X.;
York, S.;
Pierce, S.;
Brandt, M.;
Beran, M.;
Borthakur, G.;
Kantarjian, H.;
Ravandi, F.

Publication type:

journal article

Genomic approaches to small molecule discovery.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1226, doi. 10.1038/leu.2009.29

By:

Stegmaier, K.

Publication type:

Article

Chromatin maps, histone modifications and leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1243, doi. 10.1038/leu.2009.40

By:

Neff, T.;
Armstrong, S. A.

Publication type:

Article

Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1303, doi. 10.1038/leu.2009.25

By:

Chou, W.-C.;
Chen, C.-Y.;
Hou, H.-A.;
Lin, L.-I.;
Tang, J.-L.;
Yao, M.;
Tsay, W.;
Ko, B.-S.;
Wu, S.-J.;
Huang, S.-Y.;
Hsu, S.-C.;
Chen, Y.-C.;
Huang, Y.-N.;
Tseng, M.-H.;
Huang, C.-F.;
Tien, H.-F.

Publication type:

Article

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.

Published in:

2009

By:

Reeder, C. B.;
Reece, D. E.;
Kukreti, V.;
Chen, C.;
Trudel, S.;
Hentz, J.;
Noble, B.;
Pirooz, N. A.;
Spong, J. E.;
Piza, J. G.;
Zepeda, V. H. J.;
Mikhael, J. R.;
Leis, J. F.;
Bergsagel, P. L.;
Fonseca, R.;
Stewart, A. K.

Publication type:

journal article

Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia.

Published in:

2009

By:

Yánez, L.;
Bermúdez, A.;
Richard, C.;
Bureo, E.;
Iriondo, A.

Publication type:

Letter

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

Published in:

2009

By:

Tefferi, A.;
Lim, K.-H.;
Abdel-Wahab, O.;
Lasho, T. L.;
Patel, J.;
Patnaik, M. M.;
Hanson, C. A.;
Pardanani, A.;
Gilliland, D. G.;
Levine, R. L.

Publication type:

Letter

Functional characterization of an activating TEK mutation in acute myeloid leukemia: a cellular context-dependent activating mutation.

Published in:

2009

By:

Tyner, J. W.;
Rutenberg-Schoenberg, M. L.;
Erickson, H.;
Willis, S. G.;
O'Hare, T.;
Deininger, M. W.;
Druker, B. J.;
Loriaux, M. M.

Publication type:

Letter

Reduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemia.

Published in:

2009

By:

Ashton, L. J.;
Gifford, A. J.;
Kwan, E.;
Lingwood, A.;
Lau, D. T. T.;
Marshall, G. M.;
Haber, M.;
Norris, M. D.

Publication type:

Letter

A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?

Published in:

2009

By:

Ripperger, T.;
Steinemann, D.;
Göhring, G.;
Finke, J.;
Niemeyer, C. M.;
Strahm, B.;
Schlegelberger, B.

Publication type:

Letter

Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis.

Published in:

2009

By:

Silver, R. T.;
Vandris, K.

Publication type:

Letter

Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction.

Published in:

2009

By:

Mous, R.;
Jaspers, A.;
Luijks, D. M. P.;
Mellink, C. H. M.;
van Oers, M. H. J.;
Kater, A. P.;
Eldering, E.

Publication type:

Letter

LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome.

Published in:

2009

By:

Soler, G.;
Nusbaum, S.;
Varet, B.;
Macintyre, E. A.;
Vekemans, M.;
Romana, S. P.;
Radford-Weiss, I.

Publication type:

Case Study

Genomic technologies in leukemia and lymphoma: a review series.

Published in:

2009

By:

Ferrando, A. A.

Publication type:

Editorial

Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.

Published in:

2009

By:

Kern, W.;
Haferlach, C.;
Bacher, U.;
Haferlach, T.;
Schnittger, S.

Publication type:

Letter

Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.

Published in:

2009

By:

Kreyenberg, H.;
Eckert, C.;
Yarkin, Y.;
Reising, M.;
Willasch, A.;
Handgretinger, R.;
Kremens, B.;
von Stackelberg, A.;
Henze, G.;
Klingebiel, T.;
Bader, P.

Publication type:

Letter

CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1329, doi. 10.1038/leu.2009.77

By:

Takeshita, A.;
Yamakage, N.;
Shinjo, K.;
Ono, T.;
Hirano, I.;
Nakamura, S.;
Shigeno, K.;
Tobita, T.;
Maekawa, M.;
Kiyoi, H.;
Naoe, T.;
Ohnishi, K.;
Sugimoto, Y.;
Ohno, R.

Publication type:

Article

Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.

Published in:

2009

By:

Piccaluga, P. P.;
Sabattini, E.;
Bacci, F.;
Agostinelli, C.;
Righi, S.;
Salmi, F.;
Testoni, N.;
Paolini, S.;
Castagnetti, F.;
Martinelli, G.;
Falini, B.;
Pileri, S. A.

Publication type:

Letter

Introduction to the genomics spotlight.

Published in:

Leukemia (08876924), 2009, v. 23, n. 7, p. 1208, doi. 10.1038/leu.2009.97

By:

Killmann, N.

Publication type:

Article